Biostar Pharmaceuticals(OTC) BSPM

Biostar Pharmaceuticals, Inc. is a developer, manufacturer, and marketer of pharmaceutical products primarily targeting various diseases and conditions in the People's Republic of China. The company specializes in over-the-counter (OTC) and prescription medications, focusing on chronic hepatitis B and other health issues.

Products and Services

• Xin Ao Xing Oleanolic Acid capsule for chronic hepatitis B
• Ganwang compound paracetamol for cold and flu relief
• Tianqi Dysmenorrhea capsule for menstrual pain relief

Growth Outlook

• Increasing demand for OTC products in China supports revenue potential
• Expansion of product offerings may enhance market presence
• Strategic partnerships could drive growth in distribution channels

Financial Highlights

• Recent quarterly net income reported at -$125,000
• Trailing twelve months (TTM) revenue of $0 indicates challenges in sales
• Current ratio of 1.31 suggests adequate short-term financial health

Biostar Pharmaceuticals, Inc. operates in a competitive pharmaceutical landscape, focusing on addressing prevalent health issues in China. The company's product range includes both OTC and prescription medications, catering to a diverse patient base. Despite recent financial challenges, including a reported net income loss, the company maintains a solid current ratio, indicating a capacity to meet short-term obligations. The growth outlook remains promising, driven by increasing demand for OTC products and potential strategic partnerships. Investors may find interest in the company's efforts to expand its market presence and product offerings in a growing healthcare sector.